TABLE 3.
Specifications of the NF.
Description: LNFP‐I/2’‐FL is a white to off‐white powder produced by microbial fermentation and further isolated, purified and concentrated | |
---|---|
Source: A genetically modified strain (Escherichia coli K‐12 DH1 MDO MP2173b) of E. coli K‐12 DH1 (DSM 4235) | |
Parameter | Specification |
Composition | |
Specified saccharides a (% w/w DM) | ≥ 90.0 |
LNFP‐I and 2’‐FL (% w/w DM) | 75.0–100.0 |
LNFP‐I (% w/w DM) | 50.0–75.0 |
2’‐FL (% w/w DM) | 15.0–35.0 |
LNT (% w/w) | ≤ 5.0 |
3‐FL (% w/w) | ≤ 1.0 |
Sum of l‐fucose and 2′‐fucosyl‐lactitol b (% w/w) | ≤ 1.0 |
d‐Lactose (% w/w) | ≤ 10.0 |
DFL (% w/w) | ≤ 2.0 |
LNFP‐I fructose isomer (% w/w) | ≤ 1.5 |
2′‐fucosyl‐d‐lactulose (% w/w) | ≤ 1.0 |
Sum of other carbohydrates | ≤ 6.0 |
pH (5% solution, 20°C) | 4.0–7.0 |
Water (% w/w) | ≤ 8.0 |
Ash (% w/w) | ≤ 0.5 |
Protein (% w/w) | ≤ 0.01 |
Contaminants | |
Arsenic (mg/kg) | ≤ 0.2 |
Cadmium (mg/kg) | ≤ 0.1 |
Lead (mg/kg) | ≤ 0.02 |
Mercury (mg/kg) | ≤ 0.1 |
Aflatoxin M1 (μg/kg) | ≤ 0.025 |
Microbial parameters | |
Total plate count (CFU/g) | ≤ 1,000 |
Yeasts and moulds (CFU/g) | ≤ 100 |
Enterobacteriaceae (in 10 g) | ND |
Salmonella (in 25 g) | ND |
Cronobacter spp. (in 10 g) | ND |
Listeria monocytogenes (in 25 g) | ND |
Presumptive Bacillus cereus (CFU/g) | ≤ 50 |
Endotoxins (EU/mg) | ≤ 10 |
Abbreviations: 2’‐FL: 2′‐Fucosyllactose; 3‐FL: 3‐Fucosyllactose; CFU: Colony forming units; DFL: Difucosyllactose; EU: Endotoxin units; LNFP‐I: Lacto‐N‐fucopentaose I; LNT: Lacto‐N‐tetraose; ND: Not detected.
Specified saccharides include LNFP‐I, 2’‐FL, LNT, DFL, 3‐FL, d‐lactose, l‐fucose and 2′‐fucosyl‐lactitol, LNFP‐I fructose isomer and 2′‐fucosyl‐d‐lactulose.
l‐Fucose and 2′‐fucosyl‐lactitol peaks on the HPAEC–PAD chromatogram overlap.